
zzso is a common zzso zzso in persons with visceral zzso zzso syndrome and type 2 zzso zzso typically occurs in conjunction with low HDL levels and zzso small dense LDL particles and is associated with increased cardiovascular zzso zzso resistance is often an underlying feature and results in increased free fatty acid zzso delivery to the liver due to increased peripheral zzso Increased zzso zzso production occurs due to increased zzso availability via zzso decreased zzso zzso degradation and increased zzso zzso zzso also is a common feature of insulin zzso Small dense LDL that coexist with decreased HDL particles in zzso states are highly zzso due to their enhanced zzso zzso zzso binding abilities and zzso to zzso zzso also occurs in zzso individuals with type 1 diabetes but intensive zzso control zzso zzso zzso However, development of visceral obesity in these patients zzso a similar zzso profile as in patients with insulin zzso zzso zzso increases cardiovascular risk, while marked zzso should be considered a risk for zzso zzso modification is an important therapeutic zzso Drug therapy is primarily focused on lowering LDL levels with zzso since efforts at zzso lowering and HDL raising with zzso and/or zzso have not yet been shown to be beneficial in improving cardiovascular zzso zzso however, are zzso agents when marked zzso is zzso This article is part of a Special zzso entitled zzso zzso and zzso 

